Nervonik
Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions
$52.5MSeries B
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions
Develops treatments for patients suffering from thromboembolic disease
Provides rapid access to functional proteins through benchtop eProtein Discovery System